Head injuries worsen memory and thinking decades later

Phase 2 trial results show donanemab may slow decline in early Alzheimer’s


COVID-19 sees prescriptions increase for dementia drugs linked with serious side-effects


Dame Julie Walters urges government to keep its promise on dementia research funding


Poorer heart health leads to increased risk of memory and thinking decline


Dementia the second leading cause of death in February